Introduction
Over the past two decades several studies of night visiting have been carried out in various practice settings. These indicate a wide range of visiting rates as between different family practitioners. The reported annual rates for visits from 2300 to 0700 range from 7-81 to 30.02 per 1000 patients. None of these studies was, however, based on a representative sample of practices. Moreover, no inquiry has attempted to deal with the national picture as a whole. Indeed, during the greater part of the National Health Service's history, no such study could have been carried out without a special data-collecting exercise. But data tend to follow money, and since the introduction of nightvisit payments in April 1967 at least some of the information needed for such a study has become available. We have therefore used the data for all executive councils in England (excluding only the Scilly Isles) to relate geographical variations in implied night-visiting rates to the characteristics of both service providers and patient population.
National picture
Since 1967 the amount paid out in night-visit fees has increased more than thirteenfold (table I). In part, this reflects the increase in the fee per visit: this has gone up from C1 to C4 60-and so has doubled in real terms. More interesting, however, has been the growth in the number of visits claimed for: nationally, the implied visiting rate per principal rose from 10- Average of "top 10" .141
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Average of "bottom 10" In trying to interpret these variations, there is again the problem of distinguishing between the propensity to claim and the propensity to visit. But given the scale of the variations between executive councils it seems reasonable to assume that there must be other factors besides a geographically differential propensity to claim. There is, after all, no a priori ground for expecting a geographical bias in the propensity to claim; and even accepting that there are wide differences in the attitude of individual practitioners to claiming fees, it would be sur-prising if these differences would survive once averaged out among all GPs in any one executive council-and thus explain, for example, the four-fold difference between Tynemouth and Northampton. proportions of the population in social classes IV and V.
Some of these factors were included because they had been recorded' 2 5-8 as influencing visiting rates-for instance, earlier studies suggested that the age of patients and their social class might be important. Other factors were included because they seemed to be intuitively relevant-for example, population density, a hybrid factor that may be seen as pertinent to either the organisation of medical practice (since it affects the doctor's travelling times) or to community characteristics. This was included in the former group for purposes of analysis. These two factors were, in turn, related since infant mortality rates were highest in social class V." Surprisingly, the proportion of the elderly in the population seemed unimportant. Turning to the supply factors, the strongest relation was with deputising services (r = 0 520).
There was an inverse relation between visiting rates and the percentagejof GPs in partnerships of four or more (r =-0 365), but the relation with list sizes, age of GPs, and the proportion of singlehanded family practitioners was weak.
The problem in interpreting these results was that many of these factors were correlated with each other. There was not only the relation, already noted, between social class and infant mortality (r=0 543); there was also a relation between social class V and deputising services. (r=0-454). All three were related to population density. A step-wise multiple regression technique was therefore used to identify what combination of the independent variables best explained the variations in implied night-visiting rates. This was done separately for, firstly, all the variables; secondly, for those on the supply side; and, thirdly, for those on the demand side.
The results of this exercise are summarised in table IV. Looking at the first analysis, which includes all the variables, line (a) shows the equation that best explains the variations in visiting rates, using only those variables whose regression coefficients are statistically significant at the 0-05 level. Line (b) shows the regression coefficients' statistical significance. Additionally, line (c) gives a standardised measure of each variable's relative "weight" in the equation. Two factors have most effect in this explanation of the variations: deputising services and the proportion of the population in social class V. And of these two, the deputising services factor (standardised regression coefficient, src=0-61) carries more weight than social class V (src=0 44 In interpreting these results, it is important to stress that the first equation-which includes both supply and demand factors-can explain only 43 of the variations in implied visiting rates. Inevitably, the other equations explain less. The supply variables give an R2 of 0-32; the demand variables give an R2 of 0-20. Apparently, factors associated with the organisation of medical care are more important in determining visiting rates than those associated with the characteristics of the patient population. Consistent with Logan et al,12 these results support the thesis that supply of medical care is more important in shaping use than demand: it is not so much the patients as the producers-doctors and others-who effectively determine what happens. Equally, the importance of deputising services in explaining variations is consistent with the upward trend in implied visiting rates over time noted earlier, since they were increasing in the scale of their activities during the period in question. 13 Once again, however, this finding might reflect the fact that deputising services have a greater propensity to visit or simply a greater propensity to claim-or both. On the one hand, deputising services may be more ready to visit than individual practitioners, who are better placed to judge whether or not to make a visit in response to a call. On the other hand, family practitioners have more incentive to forward the claim for the night-visiting fee if they themselves are paying the deputising services. Indeed a differential propensity to claim may also contribute to the 570o of variations left unexplained by the best equation. If this were the main explanation, however, one would not expect a geographical bias in the unexplained residual. But, in fact, when implied visiting rates for executive councils are compared with therates predictedbythe equation, a regional bias emerges. In particular, two of the standard regions are more consistently above or below the expected figures than the rest: the north, where 13 out of 14 executive councils had a higher than predicted visiting rate, and the south-west, where seven out of nine executive councils had a lower than predicted rate. The General Household Survey14 shows that the north has a particularly high incidence of long-standing illness and-for men-of restricted activity days, while the south-west is well below the national average on both counts. Similarly, these two regions are somewhat different in the practice-orientation of their GPs."5 Possibly, therefore, more of the variations in night-visiting rates could be explained if better data on morbidity and GP attitudes were available for the executive council areas.
Implications for policy
Two policy issues are raised by the analysis of the data for night-visiting payments. The first is whether, counter to the BRITISH MEDICAL JOURNAL 26 MARCH 1977 829 anecdotal evidence, the rate of actual night visiting has been rising. This might reflect the fact that night visiting is increasingly being taken over by deputising services. If the rate of night visiting is seen as a measure of the care provided to the patient then the continuation of deputising services would improve performance in terms of this indicator. The second issue is why the only patient-linked factor to emerge strongly from our analysis is the proportion of the population in social class V. Other population characteristics are not significant or have little explanatory power. This might suggest that family practitioners tend to determine the level of service, irrespective of the circumstances of their patients.
Both these points underline the importance of recording GP activities, including night visits, so as to allow trends over time and variations between practices to be analysed. If it is desirable, in the words of the Committee of Enquiry into Competence to Practise,16 "for all doctors to assume responsibility for reviewing their own work with the assistance of their colleagues in similar fields of practice," then it is essential that such reviews should be based on the systematic collection of data rather than on what may be misleading, atypical information based on the experience of a handful of practices. Only on the basis of adequate information can family practitioners develop a consensus about explicit criteria to be used both in "educating" patients about when to request night calls and in deciding when to visit in response. For these criteria to depend on the idiosyncracies of individual practitioners cannot be a satisfactory state of affairs either for the medical profession or for patients. What are the respective merits and demerits of baclofen and dantrolene in treating muscle spasms in multiple sclerosis ?
Baclofen diminishes reflex activity in the spinal cord and inhibits synaptic transmission. It is related to gamma-aminobutyric acid and has been shown to have an inhibiting action on cortical and cerebellar neurones and is thought to act specifically at the spinal level. It is useful in controlling clonus and for its central sedative effect.' It is advisable to start with a low dosage and increase this gradually until an optimum effect is achieved, usually 40-60 mg/day. Dantrolene acts by reducing the force of contraction of the muscle without reduction in the relaxation time.' The initial dose should be 25 mg daily and this can be increased to 200 mg daily in divided doses. Zaimis3 suggested that beta-adrenoreceptor stimulants may also help to alleviate spasticity. These drugs increase the speed of relaxation of slow-contracting muscles and lessen the muscular hypertonia characteristic of the spastic state. Of the two drugs baclofen is more likely to help muscle spasms in multiple sclerosis, although the effect of this drug even in relatively large doses may not be very obvious.
